BioSpace News Archive

AffaMed Therapeutics, a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products, held a DEXTENZA Launch and Advisory Board Meeting recently in Macau, following DEXTENZA’s approval for the treatment of post-surgical ocular pain and inflammation.

Albireo Pharma, Inc. today announced that management will host a conference call and live audio webcast at 4:30 p.m. ET on May 16, 2022, to provide a business update and review the company’s financial results for the quarter ended March 31, 2022.

Celsion Corporation announced today that the Company will host a conference call at 11:00 a.m. ET on Monday, May 16, 2022 to discuss financial results for the first quarter ended March 31, 2022 and provide an update on product development programs.

Alaunos Therapeutics, Inc. today announced that it will report financial results for the first quarter ended March 31, 2022 on Monday, May 16, 2022, before the open of U.S. markets.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and financial results for the first quarter ended March 31, 2022.

Dyadic International, Inc. announced today the successful results and data received from the toxicology study of its DYAI-100 COVID-19 vaccine candidate.

RedHill Biopharma Ltd. today announced that it has entered into a definitive agreement with a single leading healthcare investor for the purchase and sale of 10,563,380 of the Company’s American Depositary Shares (“ADSs”).

Liminal BioSciences Inc. announced that Bruce Pritchard , Chief Executive Officer at Liminal BioSciences is scheduled to present a company overview at the following upcoming investor conference.

Elpiscience Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared Elpiscience’s ES014 Investigational New Drug (IND) Application to initiate a Phase 1 clinical study.

Virax Biolabs is pleased to announce that it has received ethical approval for its Analytical Performance Study for the Virax Immune COVID-19 Flow Cytometry Kit from the ethics committee of the Stichting Beoordeling Ethiek Biomedisch Onderzoek Foundation for the Assessment of Ethics of Biomedical Research.